Nrf2 controls iron homeostasis in haemochromatosis and thalassaemia via Bmp6 and hepcidin
Details
Publication Year 2019-05,Volume 1,Issue #5,Page 519-531
Journal Title
Nature Metabolism
Publication Type
Journal Article
Abstract
Iron is critical for life but toxic in excess because of iron-catalysed formation of pro-oxidants that cause tissue damage in a range of disorders. The Nrf2 transcription factor orchestrates cell-intrinsic protective antioxidant responses, and the peptide hormone hepcidin maintains systemic iron homeostasis, but is pathophysiologically decreased in haemochromatosis and beta-thalassaemia. Here, we show that Nrf2 is activated by iron-induced, mitochondria-derived pro-oxidants and drives Bmp6 expression in liver sinusoid endothelial cells, which in turn increases hepcidin synthesis by neighbouring hepatocytes. In Nrf2 knockout mice, the Bmp6-hepcidin response to oral and parenteral iron is impaired and iron accumulation and hepatic damage are increased. Pharmacological activation of Nrf2 stimulates the Bmp6-hepcidin axis, improving iron homeostasis in haemochromatosis and counteracting the inhibition of Bmp6 by erythroferrone in beta-thalassaemia. We propose that Nrf2 links cellular sensing of excess toxic iron to control of systemic iron homeostasis and antioxidant responses, and may be a therapeutic target for iron-associated disorders.
Publisher
Springer Nature
Research Division(s)
Population Health And Immunity
PubMed ID
31276102
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2019-07-17 01:31:56
Last Modified: 2020-02-03 08:23:40
An error has occurred. This application may no longer respond until reloaded. Reload 🗙